智飞生物公告：新冠疫苗对Delta病毒保护率78%！辉瑞有效性下降至16%？_接种

业内人士分析称，随着FDA全面批准了辉瑞的mRNA新冠疫苗，将一定程度上打消美国人对接种新冠疫苗的恐慌情绪，让更多的美国人相信新冠疫苗是安全的，可能会出现新一波疫苗接种高峰。 其实，美国FDA完全批…

Related Keywords

Germany ,New York ,United States ,Taiwan ,Shanghai ,China ,Thailand ,Israel ,White House ,District Of Columbia ,Chile ,South Korea ,Macau ,Korea ,Hui Crown ,Morgan Stanley ,United States Department Of Defense ,University Of Oxford ,China Sinopharm Group ,Israel Ministry Of Health ,Korea Pearl Group ,New York Times ,Notice New Crown ,Hui Switzerland ,New Crown ,Hui New Crown ,Medical Consultant ,Spring United States ,United States Department ,Prime Minister ,August Israel ,Hui Switzerland Disclosure ,Israel Ministry ,Goes New Crown ,Germany Law ,Country New Crown ,August China Sinopharm Group ,State Department ,Municipal City Hall ,Macau Region ,China Taiwan Region ,Sohu View ,变异 ,美国 ,数据 ,疫苗 ,病毒 ,接种 ,Delta ,保护率 ,效力 ,智飞生物 ,辉瑞 ,新冠 ,